Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs clonidine for haloperidol-resistant ICU delirium
2013-003547-39Phase 4Completed
- Sponsor
- Isala
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in delirium comparing Dexmedetomidine arm with Clonidine arm (2 arms). Primary endpoint: Duration of alpha2-agonist treatment until sustained delirium resolution. Started Sep 2013; status: completed.
02
Drugs
dexmedetomidineclonidine
03
Conditions
delirium
Beyond the preview
Go deeper on 2013-003547-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003547-39.